Tekturna Overdose

Because Tekturna (aliskiren) is a relatively new medication, little information is available about potential effects in the case of an overdose. However, taking too much Tekturna could likely result in low blood pressure. Treatment for a Tekturna overdose may include pumping the stomach, inducing vomiting, or treating the symptoms that occur as a result of the overdose.

 

Tekturna Overdose: An Introduction

Tekturna® (aliskiren hemifumarate) is a prescription high blood pressure medication. It is the first medication classified as a renin inhibitor. As with any medication, it is possible to take too much Tekturna. The specific effects of a Tekturna overdose can vary, depending on a number of factors, including the Tekturna dosage and whether it was taken with any other medications or substances.
 

Effects of a Tekturna Overdose

Because Tekturna is a relatively new medication, little information is available about potential effects of an overdose. However, it is predicted that low blood pressure (hypotension) may result from a Tekturna overdose. Signs of low blood pressure include lightheadedness, dizziness, and fainting.
 

Treatment for a Tekturna Overdose

The treatment for a Tekturna overdose will also vary.
 If the overdose was recent, a healthcare provider may "pump the stomach" or administer certain medications to induce vomiting. Treatment may also involve supportive care, which consists of treating the symptoms that occur as a result of the overdose. For example, supportive treatment options for an overdose may include:
 
  • Careful monitoring of the heart, blood pressure, and breathing
  • Medications to increase blood pressure, if dangerously low blood pressure occurs
  • Fluids through an intravenous line (IV)
  • Other treatments based on complications that occur.
     
It is important that you seek medical attention immediately if you believe you may have overdosed on Tekturna.
 
Add this article to your Favorites     Email this article     Print
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;